SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

$BYTE.X is trending as community members rally around this self-proclaimed 'chosen one' in the AI companionship space. The coin's connection to AI and a strong community are key talking points, with many expressing long-term bullish sentiment. Some users are pointing to the coin as the one to watch in the AI-driven meme coin sector.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel $INTC is trending amid speculation of a potential investment from Apple and closer collaboration between the two companies, fueling optimism about Intel's turnaround. Community members are discussing potential price targets and the impact of government support, while analysts debate the sustainability of the recent rally. Some investors believe that Intel's advanced packaging business is a key growth driver that is being overlooked.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending due to Jane Street's recent acquisition of a significant stake in the company, signaling strong institutional confidence. The community is speculating on the implications of this investment, with some suggesting a potential merger, strategic partnership, or gamma squeeze. Bullish investors are urging others to hold firm, anticipating further upward movement and a potential short squeeze.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure ($QURE) is trending after positive Phase I/II data for its Huntington's disease treatment, showing a significant slowing of disease progression, although the treatment remains in early stages. The community is focused on a potential offering given the stock's surge, debating whether it's a buying opportunity or a chance to short, especially with analysts raising price targets. Discussions also involve the drug's potential market and approval timeline, with some comparing it to other biotech plays.

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Immuneering Corp - Ordinary Shares Class A

IMRX is trending due to positive Phase 2a trial data for its pancreatic cancer treatment, showing a high survival rate. The community is discussing the potential for this to become a significant advancement in cancer treatment, although some are wary of potential dilution due to the company's financial situation and potential short selling.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to excitement around its potential in the quantum computing sector, fueled by recent non-dilutive funding for key technology advancements. Community members are actively discussing the stock's momentum and debating its valuation, comparing it to other quantum computing stocks and even established tech companies. Some traders express optimism about long-term growth, while others caution against a potential pullback.

Stitch Fix, Inc. engages in the provision of personalized shipments of apparel, shoes, and accessories. Its main sections are men's, kids, petite, maternity, and plus apparels. The company was founded by Katrina Lake and Erin Morrison Flynn in February 2011 and is headquartered in San Francisco, CA.

Stitch Fix Inc - Ordinary Shares - Class A

Stitch Fix Inc

Stitch Fix is trending following its Q4 earnings report, with community discussions focusing on whether the company's turnaround strategy is gaining traction and its ability to achieve future growth.  Investors are weighing the positive aspects of the report against concerns about revenue guidance and declining active clients.  Overall sentiment appears divided as some view the recent activity as a potential fade while others anticipate further gains.

TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

TNF Pharmaceuticals Inc.

TNF Pharmaceuticals is trending due to its announced shift into quantum computing and rebranding, sparking significant community discussion. While some view this pivot and associated name change as a promising move into a high-growth sector, others express skepticism, citing the company's history and concerns about potential pump-and-dump schemes. The community is actively debating the company's prospects and the potential impact of its new technology on the cryptocurrency industry.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz is trending as investors discuss its recent offering of exchangeable senior notes and a settlement distribution. Community members are debating the implications of the new debt versus the cash influx, with some eyeing a potential rally due to high short interest. Broader conversations include Hertz's leveraged position regarding interest rates and its ongoing recovery from bankruptcy.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is trending as traders discuss its potential to catch up with the recent gains of other Chinese tech stocks like BABA and BIDU, with some highlighting its attractive valuation and strong logistics network. Community members are actively debating potential catalysts, technical indicators, and optimal entry points, while also closely monitoring option activity and potential price targets. Despite some frustration with recent performance, there is a general sentiment of bullishness and anticipation for a breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Evogene Ltd (EVGN) shares doubled on Tuesday after the company said it had completed version 1.0 of its new generative AI foundation model for small molecule design, developed in partnership with Google Cloud.&nbsp;The model significantly upgrades Evogene’s ChemPass AI platform, helping accelerate the discovery of novel compounds that meet complex pharma and agri-industry needs.The company’s stock closed at seven-month highs on Tuesday and notched its best day on record.Unlike traditional AI, Evogene said its model was built in-house and trained on Google Cloud’s infrastructure.&nbsp;The company said its platform can now generate new molecules while meeting multiple design constraints, which is critical to drug development and agricultural chemical design.Evogene said its internal tests show a nearly 90% success in generating precise, novel molecules, vastly outperforming traditional generative AI models, which clock in around 29%.The company said it is already developing a second version of its generative AI model.On Stocktwits, the announcement sent EVGN's 24-hour message volume soaring 41,400%—the highest among all healthcare stocks—while its follower count rose by over 7%.<figure class="image"><img style="aspect-ratio:1310/182;" src="https://news.stocktwits-cdn.com/EVGN_sentiment_and_message_volume_as_of_Jun_10_png_22e2171c28.webp" alt="EVGN sentiment and message volume as of Jun 10.png" width="1310" height="182"><figcaption>EVGN sentiment and message volume as of Jun 10. | source: Stocktwits</figcaption></figure>The sentiment score for EVGN ended at ‘extremely bullish’ (99/100), reaching its peak this year.“Keep it strong all day long. Don't let the short scare you. You're holding gold,” said one user, who expects the stock to go to $5.<stembedurl>https://stocktwits.com/Strikeeeee/message/617464134</stembedurl>Israel-based Evogene is a biotech firm that uses AI and computational biology to develop new solutions in agriculture, health, and industry.&nbsp;Its platform helps discover and optimize products like seed traits, crop protection chemicals, microbiome-based therapies, and industrial-use crops.<a href="https://stocktwits.com/symbol/EVGN">Evogen’s stock</a> is up nearly 16% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Evogene Becomes Talk Of Retail Town As Stock Doubles On GenAI Drug, Agri Discovery Model With Google Cloud

The company said its internal tests show a nearly 90% success in generating precise, novel molecules, vastly outperforming traditional generative AI models.

Equity

The company said its internal tests show a nearly 90% success in generating precise, novel molecules, vastly outperforming traditional generative AI models.


Evogene Schedules Fourth Quarter 2024 Financial Results Release

Evogene Schedules Fourth Quarter 2024 Financial Results Release Evogene Schedules Fourth Quarter 2024 Financial Results Release PR Newswire REHOVOT, Israel, Feb. 20, 2025 Zoom conference call...

AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease

AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease PR Newswire...

Evogene Reports Third Quarter 2024 Financial Results

Evogene Reports Third Quarter 2024 Financial Results Evogene Reports Third Quarter 2024 Financial Results PR Newswire REHOVOT, Israel, Nov. 21, 2024 Conference call and webcast: today, November 21...

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy...

Lavie Bio Announces Commercial Expansion of Yalos as Seed-Treatment for Soybean, Following Successful Field Trials

Lavie Bio Announces Commercial Expansion of Yalos as Seed-Treatment for Soybean, Following Successful Field Trials Lavie Bio Announces Commercial Expansion of Yalos as Seed-Treatment for Soybean...

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.

Evogene Ltd

Will Costco Wholesale ($COST) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

Stocktwits

Costco Wholesale Corp

) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.43	--	--	N/A
Q2 '25	-$0.63	-$0.50	20.63%	BEAT
Q1 '25	-$0.50	-$0.38	24.75%	BEAT
Q4 '24	-$0.73	$0.06	108.28%	BEAT
Q3 '24	-$1.01	-$1.31	-29.70%	MISSED

EVGN
Evogene Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest EVGN News

EVGN Evogene Ltd